J’Onco Mentor Version 9.09 — THYROID PRIMARY

Desktop version. Mobile app coming.

WHAT IS J’ONCO MENTOR?LUNGBREASTHEAD & NECKPROSTATEENDOMETRIUMLIVERADRENAL GLANDKIDNEYTHYROIDBLADDERCOLON & RECTUMMELANOMA OF SKINPANCREASSTOMACHCNSHEMATOPOIETIC DISORDERSTOP CANCER SITESSTORE MANUALRADIATION GUIDESTATE REPORTABILITYICD-10-CM / SECONDARY DXODS RESOURCES

DIAGNOSIS YEAR

Select the diagnosis year first. J’Onco Mentor uses it to establish the standards cycle and to drive year-sensitive routing in this module.

SEER manual—
NAACCR cycle—
Staging context—
Standards statusSelect year
No diagnosis year selected. Year-dependent schema, staging, SSDI, grade, surgery, and manual guidance should not be assumed.

INTERACTIVE THYROID ANATOMY

Realistic thyroid anatomy showing right lobe, left lobe, isthmus, larynx and trachea

SELECT ONE OR MORE THYROID REGIONS


Select multiple regions directly, or use the anatomy hotspots/buttons. Right lobe + left lobe will display as bilateral involvement.

Topography: Thyroid gland is coded C73.9. Right/left lobe and isthmus are anatomic regions, not separate ICD-O topography codes.
Selected region(s): —

IMAGING — STANDARD THYROID VIEWS

2D Ultrasound

  • Transverse views of each lobe: superior, mid, inferior.
  • Longitudinal views of each lobe: medial, mid, lateral.
  • Isthmus: transverse image with AP thickness measurement.
  • Document nodules in at least two orthogonal planes with three-dimensional measurements.

3D / Volumetric Imaging

  • Acquire a volumetric dataset when 3D imaging is used.
  • Reconstruct in axial/transverse, sagittal/longitudinal and coronal planes.
  • Use the volumetric views to supplement, not replace, standard diagnostic documentation.

THYROID HISTOLOGY / SCHEMA ROUTING

Type a code or name, or use the dropdown below. Both controls stay synchronized.

SELECTED HISTOLOGY

—

SCHEMA / AJCC ROUTING

—

Select histology.

For 2026, differentiated and anaplastic thyroid carcinomas use AJCC 8 Chapter 73; medullary thyroid carcinoma uses AJCC 8 Chapter 74 when eligible.

BETHESDA / ODS REPORTABILITY

REPORTABILITY RESULT

—

Select a Bethesda category.

SEER thyroid reportability: Bethesda VI is reportable in the absence of information to the contrary. Bethesda V is not reportable unless additional information confirms a reportable diagnosis. TI-RADS categories alone do not establish reportability.

BRAF / MOLECULAR — THYROID

BRAF V600E

Most strongly associated with papillary thyroid carcinoma and can also occur in some poorly differentiated or anaplastic thyroid carcinomas.

ODS REPORTABILITY

BRAF-positive ≠ a cancer diagnosis by itself.

A positive BRAF result alone does not automatically establish a reportable thyroid cancer diagnosis. Genetic findings without pathologic or clinical evidence of reportable disease are risk/prognostic information, not a diagnosis.

What to look for

Look for a reportable pathology/cytology diagnosis or a recognized medical practitioner's clinical diagnosis of malignancy. Bethesda VI is reportable in the absence of contrary information; Bethesda V requires additional confirmation.

Clinical context: BRAF status may influence prognosis and treatment decisions, but it should not be used alone to accession a thyroid cancer case.

AJCC STAGING

PATHOLOGIC STAGING CRITERIA — THYROID

Qualifying evidence: Thyroid lobectomy or thyroidectomy generally supports pathological evaluation of primary tumor extent (pT). Examined regional lymph nodes can support pN. Age, histologic type, and the applicable chapter affect stage grouping.

pT / pN: Assign only categories supported by the actual pathological evidence and the site-specific AJCC rules. A diagnosis-confirming biopsy does not automatically establish a pathological primary tumor category.

pM: Pathologically proven distant metastasis may support pM1 where the chapter permits; AJCC does not use pM0.

Treatment sequence: Distinguish initial pathological classification (pTNM) from post-neoadjuvant classification (ypTNM). Confirm eligibility, histology, staging chapter and diagnosis-year edition before finalizing.

Source / verification: AJCC · SEER tools and manuals. Educational overview only; verify exact chapter-specific criteria in the licensed AJCC manual.

Thyroid AJCC staging schema / TNM context

Use the T, N and M controls and site-specific factors below. Verify final AJCC ID, TNM edition and stage group in the approved AJCC/SEER staging system for the diagnosis year.





AJCC RESULT

—

Select histology and staging inputs.

AJCC ID—
TNM Edition—
Differentiated thyroid stage grouping is age-dependent at the AJCC 8 cutoff of 55 years. Medullary thyroid and anaplastic thyroid use distinct stage-group rules.

REGIONAL LYMPH NODES

Central compartment

Prelaryngeal, pretracheal and paratracheal nodes; Level VI and upper mediastinal Level VII are central compartment nodes.

Lateral neck

Levels I–V are lateral cervical nodal groups. Exact N category depends on histologic staging system.

ODS reminder

Do not infer N category solely from the word “cervical.” Use the documented nodal level/location and the applicable AJCC/EOD schema.

EOD / SUMMARY STAGE

SEER*RSA

Thyroid gland C73.9 routes to the appropriate thyroid EOD schema based on histology, including differentiated/anaplastic versus medullary pathways.

Summary Stage

Use the diagnosis-year SEER*RSA tables for exact localized, regional and distant definitions. Do not convert AJCC stage groups directly into Summary Stage.

SURGERY — THYROID GLAND (2026)

—
Select a procedure.

COMMON METASTATIC SITES — THYROID

Lung

Common distant site, especially for differentiated thyroid carcinoma.

Bone

Frequent site of distant spread in differentiated and medullary disease.

Liver

Can occur in advanced thyroid malignancy.

Brain

Less common but recognized distant metastatic site.

SOURCES

2027 standards cycle: Use the 2027 SEER Program Coding and Staging Manual, Solid Tumor Rules 2027, STORE 2027, NAACCR v27 resources, Summary Stage v3.4, and the current diagnosis-year SEER*RSA/EOD schema as applicable. Historical cases may require prior-year instructions.